Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Colorectal Neoplasms × Nivolumab × Clear all

Phase

Phase 2 30 Phase 1 23 Phase 1/2 21 Phase 3 2 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 7 Stomach Neoplasms 3 Adenocarcinoma Of Esophagus 3 Uveal Melanoma 2 Carcinoma, Hepatocellular 2 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Prostatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Hepatitis B 1 Gliosarcoma 1 GATA2 Deficiency 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Advanced or Metastatic Solid Malignancies 1 Adenocarcinoma of Lung 1

Interventions

Oxaliplatin 15 Fluorouracil 13 Bevacizumab 12 Leucovorin 10 Capecitabine 8 Folfox protocol 7 Irinotecan 5 IFL protocol 4 Cetuximab 4 Folic Acid 3 Aspirin 3 atezolizumab 2 XELOX 2 Surgical Procedures, Operative 2 Magnetic Resonance Spectroscopy 2 Drug Therapy 2 Chemotherapy, Adjuvant 2 trifluridine tipiracil drug combination 1 trametinib 1 titanium silicide 1 sulindac sulfone 1 spartalizumab 1 sacituzumab govitecan 1 regorafenib 1 raltitrexed 1 pertuzumab 1 folfirinox 1 envafolimab 1 dabrafenib 1 cobimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03414983 2023-11-18

CheckMate 9X8

Bristol-Myers Squibb

Phase 2/3 Completed

196 enrolled 26 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡